OS Therapies OSTX
NYSE OSTX
$1.29 +0.03 (+2.39%)
As of: Oct 21, 2026 · 12:41 PM EDT

OS Therapies (OSTX) Preferred Shares (2023 - 2024)

Updated

OS Therapies (OSTX) reported Preferred Shares of $8.16 million for Q4 2024, compared with $1,302 a year earlier.

Analysis

OS Therapies (OSTX) Preferred Shares (2023 - 2024) Analysis & Trends

  • By year, Preferred Shares came in at $1,302 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,131.52 Bn 1,100.11 Bn 19.71 Bn -
2 Johnson & Johnson 616.33 Bn 534.86 Bn 17.26 Bn -
3 AbbVie 500.08 Bn 473.19 Bn 12.70 Bn -
4 Merck 366.80 Bn 321.17 Bn 12.21 Bn -
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn -
6 Astrazeneca 261.59 Bn 235.28 Bn 12.86 Bn -
7 Amgen 234.86 Bn 190.26 Bn 7.24 Bn -
8 Gilead Sciences 189.95 Bn 164.15 Bn 6.22 Bn -
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn -
10 OS Therapies 6.16 Mn 2.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 8.16 Mn
Dec 31, 2023 1,302.00
API Access

OS Therapies Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=OSTX&period=max&api_key=YOUR_API_KEY